Celladon Corporation Appoints Elizabeth E. Reed General Counsel
SAN DIEGO, June 9, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced it has appointed Elizabeth E. Reed as Vice President and General Counsel.
Help employers find you! Check out all the jobs and post your resume.